Research Report Screener Results

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 23-Nov-2009
New Screen

All Reports | Brokerage Reports | Independent Reports

All Reports (Showing 1 to 10 of 70)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
21-Nov-09 Standard & Poor's STARS Report N/A Covidien Plc 7 $35 View Abstract
21-Nov-09 Reuters Investment Profile N/A Inversiones Covadonga SA: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 12 $20 View Abstract
21-Nov-09 Reuters Investment Profile N/A Canadian Orebodies Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 12 $20 View Abstract
21-Nov-09 Reuters Investment Profile N/A Covalon Technologies Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 12 $20 View Abstract
21-Nov-09 Reuters Investment Profile N/A Corvette Resources Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 12 $20 View Abstract
20-Nov-09 New Constructs, LLC N/A COV: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings 19 $10 View Abstract
20-Nov-09 Ford Investor Services, Inc. N/A Value Graph: COVIDIEN PLC -- COV 1 $4 View Abstract
20-Nov-09 Ford Investor Services, Inc. N/A Industry Value Graph: BSX , COV , HSP , LUX , MDT , SNN , SYK , ZMH -- MEDICAL SUPPLIES & EQUIPMENT 3 $4 View Abstract
19-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Plunkett's Health Care Technologies Overview 2010 (Summary) 80 $199 View Abstract
19-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Health Care Industry Market Research and Competitive Analysis 2010 730 $299 View Abstract
Next 20

Brokerage Reports (Showing 1 to 8 of 8)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
18-Nov-09 Caris & Company Chris Warren COV-F10 Guidance Raised Despite Additional SG&A Spend 8 $25 View Abstract
18-Nov-09 Morgan Keegan & Company, Inc. N/A First Look - Nov 18 2009 08:03AM 12 $25 View Abstract
18-Nov-09 Thomson StreetEvents N/A COV - Event Transcript of Covidien Plc. conference call, Nov. 17, 2009 / 8:30am ET 22 $75 View Abstract
18-Nov-09 Thomson StreetEvents N/A COV - Event Brief of Covidien Plc. conference call, Nov. 17, 2009 / 8:30am ET 25 $75 View Abstract
18-Nov-09 Thomson StreetEvents N/A COV - Event Transcript of Covidien Plc. conference call, Nov. 18, 2009 / 11:30am ET 8 $75 View Abstract
17-Nov-09 Morgan Keegan & Company, Inc. Lawrence S. Keusch Covidien (COV): Initiating Coverage with a Market Perform Rating 8 $25 View Abstract
17-Nov-09 Morgan Keegan & Company, Inc. Lawrence S. Keusch COV: Initiating Coverage with a Market Perform Rating 20 $50 View Abstract
12-Nov-09 Thomson StreetEvents N/A COV - Event Transcript of Covidien Plc. conference call, Nov. 11, 2009 / 5:00pm ET 8 $75 View Abstract

Independent Reports (Showing 1 to 10 of 62)

Release
Date Contributor Author Title Pages Price More Info
21-Nov-09 Standard & Poor's STARS Report N/A Covidien Plc 7 $35 View Abstract
21-Nov-09 Reuters Investment Profile N/A Inversiones Covadonga SA: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 12 $20 View Abstract
21-Nov-09 Reuters Investment Profile N/A Canadian Orebodies Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 12 $20 View Abstract
21-Nov-09 Reuters Investment Profile N/A Covalon Technologies Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 12 $20 View Abstract
21-Nov-09 Reuters Investment Profile N/A Corvette Resources Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 12 $20 View Abstract
20-Nov-09 New Constructs, LLC N/A COV: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings 19 $10 View Abstract
20-Nov-09 Ford Investor Services, Inc. N/A Value Graph: COVIDIEN PLC -- COV 1 $4 View Abstract
20-Nov-09 Ford Investor Services, Inc. N/A Industry Value Graph: BSX , COV , HSP , LUX , MDT , SNN , SYK , ZMH -- MEDICAL SUPPLIES & EQUIPMENT 3 $4 View Abstract
19-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Plunkett's Health Care Technologies Overview 2010 (Summary) 80 $199 View Abstract
19-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Health Care Industry Market Research and Competitive Analysis 2010 730 $299 View Abstract
Next 20

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.